When dealing with patients who have complex sinus disease who have failed a number of treatments, there are still various approaches the otolaryngologist–head and neck surgeon can use.

Early data on stimulation of Heschl’s gyrus are promising, but more research is needed
One of the enjoyable aspects of our specialty is the variety of patients and problems we see every day.
A new, minimally invasive technology known as balloon sinuplasty can safely and successfully dilate blocked sinus ostia in select patients with chronic sinusitis, according to early observations in a small number of patients.
Patients with head and neck squamous cell carcinoma (HNSCC) who have no history of tobacco or significant alcohol use appear to be more likely to present with earlier disease and smaller initial T-stage, but have worse than expected outcomes.
This January, the Medicare Prescription Drug Benefit, created by the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (MMA), took effect.